Your browser doesn't support javascript.
loading
Addressing Personal Protective Equipment (PPE) Decontamination: Methylene Blue and Light Inactivates SARS-CoV-2 on N95 Respirators and Masks with Maintenance of Integrity and Fit
Thomas S Lendvay; James Chen; Brian H Harcourt; Florine E.M. Scholte; F. Selcen Kilinc-Balci; Ying Ling Lin; Molly M Lamb; Larry F Chu; Amy Price; David Evans; Yi-Chan Lin; Christopher N Mores; Jaya Sahni; Kareem B Kabra; Eric Haubruge; Etienne Thiry; Belinda Heyne; Jan Laperre; Sarah Simmons; Jan Davies; Yi Cui; Thor Wagner; Tanner Clark; Sarah J Smit; Rod Parker; Thomas Gallagher; Emily Timm; Louisa F Ludwig-Begall; Nicolas Macia; Cyrus Mackie; Karen Hope; Ken Page; Susan Reader; Peter Faris; Oliver Jolois; Alpa Patel; Jean-Luc Lemyre; Vanessa Molly-Simard; Kamonthip Homdayjanakul; Sarah R Tritsch; Constance Wielick; Mark Mayo; Rebecca Malott; Jean-Francois Willaert; Hans Nauwynck; Loréne Dams; Simon De Jaeger; Lei Liao; Mervin Zhao; Steven Chu; John Conly; May C Chu.
Afiliação
  • Thomas S Lendvay; University of Washington School of Medicine, Department of Urology, Seattle Children's Hospital, Seattle, Washington, USA
  • James Chen; University of Washington School of Medicine, Department of Urology, Seattle, Washington, USA
  • Brian H Harcourt; Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for
  • Florine E.M. Scholte; Department of Infectious Diseases, Microbiology and Immunology, CRCHU de Québec-Université, Laval, Québec City, Québec, Canada
  • F. Selcen Kilinc-Balci; National Personal Protective Technology Laboratory (NPPL), Nathional Institue for Occupational Safety and Health, Centers for Disease Control and Prevention, Pi
  • Ying Ling Lin; World Health Organization
  • Molly M Lamb; Center for Global Health, Colorado School of Public Health, Anschutz Medical Campus, Aurora, Colorado, USA
  • Larry F Chu; The AIM Lab, Stanford University School of Medicine, Stanford, California, USA
  • Amy Price; The AIM Lab, Stanford University School of Medicine, Palo Alto, California, USA
  • David Evans; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada
  • Yi-Chan Lin; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada
  • Christopher N Mores; Department of Global Health, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA
  • Jaya Sahni; Seattle Children's Research Institute, Seattle Children's Hospital, Seattle, Washington, USA
  • Kareem B Kabra; Department of Global Health, Milken Institute School of Public Health, The George Washington University,Washington, DC, USA
  • Eric Haubruge; Gembloux AgroBioTech, Terra Research Center, Universityof Liége, Gembloux, Belgium
  • Etienne Thiry; Department of Infectious and Parasitic Diseases, Faculty of Veterinary Medicine, University of Liége, Liége, Belgium
  • Belinda Heyne; Department of Chemistry, University of Calgary, Calgary, Alberta, Canada
  • Jan Laperre; Centexbel, Grace-Hollogne, Belgium
  • Sarah Simmons; W21C Research and Innovation Centre, University of Calgary, Calgary, Alberta, Canada
  • Jan Davies; W21C Research and Innovation Centre, University of Calgary, Calgary, Alberta, Canada. Alberta Health Services, Alberta, Canada. Department of Anesthesiology, Pe
  • Yi Cui; Department of Materials Science and Engineering, Stanford University, Stanford, California, USA
  • Thor Wagner; Seattle Children's Research Institute, Seattle Children's Hospital, Seattle, Washington, USA
  • Tanner Clark; University of Washington School of Medicine, Department of Radiology, Seattle, Washington, USA
  • Sarah J Smit; Nelson Laboratories, LLC, Salt Lake City, Utah, USA
  • Rod Parker; Stryker, Quebec, Canada
  • Thomas Gallagher; Department of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois, USA
  • Emily Timm; Department of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois, USA
  • Louisa F Ludwig-Begall; Department of Infectious and Parasitic Diseases, Faculty of Veterinary Medicine, University of Liége, Liége, Belgium
  • Nicolas Macia; Department of Chemistry, University of Calgary, Calgary, Alberta, Canada
  • Cyrus Mackie; Department of Chemistry, University of Calgary, Calgary, Alberta, Canada
  • Karen Hope; Alberta Health Services, Alberta, Canada
  • Ken Page; Alberta Health Services, Alberta, Canada
  • Susan Reader; Alberta Health Services, Alberta, Canada
  • Peter Faris; Alberta Health Services, Alberta, Canada
  • Oliver Jolois; Centexbel, Grace-Hollogne, Belgium
  • Alpa Patel; Nelson Laboratories, LLC, Salt Lake City, Utah, USA
  • Jean-Luc Lemyre; Stryker, Quebec, Canada
  • Vanessa Molly-Simard; Stryker, Quebec, Canada
  • Kamonthip Homdayjanakul; Center for Global Health, Colorado School of Public Health, Anschutz Medical Campus, Aurora, Colorado, USA
  • Sarah R Tritsch; Department of Global Health, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA
  • Constance Wielick; Department of Infectious and Parasitic Diseases, Faculty of Veterinary Medicine, University of Liége, Liége, Belgium
  • Mark Mayo; British Standards Institution, London, UK
  • Rebecca Malott; W21C Research and Innovation Centre, University of Calgary, Calgary, Alberta, Canada
  • Jean-Francois Willaert; Stryker, Quebec, Canada
  • Hans Nauwynck; Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium
  • Loréne Dams; Department of Infectious and Parasitic Diseases, Faculty of Veterinary Medicine, University of Liége, Liége, Belgium
  • Simon De Jaeger; Gembloux AgroBioTech, Terra Research Center, University of Liége, Gembloux, Belgium
  • Lei Liao; 4CAir, Inc., Sunnyvale, California, USA
  • Mervin Zhao; 4CAir, Inc., Sunnyvale, California, USA
  • Steven Chu; Departments of Physics, Molecular and Cellular Physiology, Stanford University, Stanford, California, USA
  • John Conly; W21C Research and Innovation Centre, University of Calgary, Calgary, Alberta, Canada. Alberta Health Services, Alberta, Canada.
  • May C Chu; Center for Global Health, Colorado School of Public Health, Anschutz Medical Campus, Aurora, Colorado, USA
Preprint em Inglês | medRxiv | ID: ppmedrxiv-20236919
ABSTRACT
BackgroundThe coronavirus disease 2019 (COVID-19) pandemic has resulted in severe shortages of personal protective equipment (PPE) necessary to protect front-line healthcare personnel. These shortages underscore the urgent need for simple, efficient, and inexpensive methods to decontaminate SARS-CoV-2-exposed PPE enabling safe reuse of masks and respirators. Efficient decontamination must be available not only in low-resourced settings, but also in well-resourced settings affected by PPE shortages. Methylene blue (MB) photochemical treatment, hitherto with many clinical applications including those used to inactivate virus in plasma, presents a novel approach for widely applicable PPE decontamination. Dry heat (DH) treatment is another potential low-cost decontamination method. MethodsMB and light (MBL) and DH treatments were used to inactivate coronavirus on respirator and mask material. We tested three N95 filtering facepiece respirators (FFRs), two medical masks (MMs), and one cloth community mask (CM). FFR/MM/CM materials were inoculated with SARS-CoV-2 (a Betacoronavirus), murine hepatitis virus (MHV) (a Betacoronavirus), or porcine respiratory coronavirus (PRCV) (an Alphacoronavirus), and treated with 10 {micro}M MB followed by 50,000 lux of broad-spectrum light or 12,500 lux of red light for 30 minutes, or with 75{degrees}C DH for 60 minutes. In parallel, we tested respirator and mask integrity using several standard methods and compared to the FDA-authorized vaporized hydrogen peroxide plus ozone (VHP+O3) decontamination method. Intact FFRs/MMs/CM were subjected to five cycles of decontamination (5CD) to assess integrity using International Standardization Organization (ISO), American Society for Testing and Materials (ASTM) International, National Institute for Occupational Safety and Health (NIOSH), and Occupational Safety and Health Administration (OSHA) test methods. FindingsOverall, MBL robustly and consistently inactivated all three coronaviruses with at least a 4-log reduction. DH yielded similar results, with the exception of MHV, which was only reduced by 2-log after treatment. FFR/MM integrity was maintained for 5 cycles of MBL or DH treatment, whereas one FFR failed after 5 cycles of VHP+O3. Baseline performance for the CM was variable, but reduction of integrity was minimal. InterpretationMethylene blue with light and DH treatment decontaminated masks and respirators by inactivating three tested coronaviruses without compromising integrity through 5CD. MBL decontamination of masks is effective, low-cost and does not require specialized equipment, making it applicable in all-resource settings. These attractive features support the utilization and continued development of this novel PPE decontamination method.
Licença
cc_by
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Estudo prognóstico Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Estudo prognóstico Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
...